Newsclip®: [Health] How Colombia's Drugs Battle With Novartis Could Change Healthcare in Latin America | AS/COA

"A showdown with the Swiss drugmaker is testing Colombia's progressive new healthcare reforms. An ambitious healthcare reform in Colombia may be facing its toughest challenge yet: the pharmaceutical industry. In a bold step with wide repercussions for Latin America’s healthcare sector and drug patent law, Colombia’s Ministry of Health in late April moved to unilaterally end Swiss drug giant Novartis’ patent on the expensive cancer treatment Glivec after the company refused to sell it at lower cost. This would be the country's first-ever “compulsory license,” which is when a government allows generic drug production without consent from the patent owner. ",

0 comments | 1 clip



Last clipped by

Hey! Thanks for checking out Newsclip®!

Click on this Trending Newsclip® Stack to read other top media reports on this topic.

Be sure to clip to your personal newspaper, like, comment and share!

Newsclip® is the leader of Social News Discovery®.

Welcome to the Newsclip® beta release!

Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.

Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!

Invite Friends to Newsclip®

Invite your Facebook friends to follow you!

You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.